#CNBC Lilly CEO: U.K. has gone from biopharma leader to laggard


Lilly CEO: U.K. has gone from biopharma leader to laggard
Lilly CEO Dave Ricks explains why pricing dynamics in the U.K. make it a very unattractive place for Lilly to invest.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”
#MILENIO

コメントを送信